Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126004111 | 12600411 | 1 | I | 20150905 | 20160720 | 20160727 | 20160727 | EXP | FR-ABBVIE-16P-056-1685994-00 | ABBVIE | 40.39 | YR | F | Y | 0.00000 | 20160727 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126004111 | 12600411 | 1 | PS | NORVIR | RITONAVIR | 1 | Oral | UNKNOWN | 20945 | 100 | MG | CAPSULE | QD | ||||||
| 126004111 | 12600411 | 2 | SS | NORVIR | RITONAVIR | 1 | Oral | UNKNOWN | 20945 | 100 | MG | CAPSULE | BID | ||||||
| 126004111 | 12600411 | 3 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | 0 | 800 | MG | FILM-COATED TABLET | QD | |||||||
| 126004111 | 12600411 | 4 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | 0 | 600 | MG | FILM-COATED TABLET | BID | |||||||
| 126004111 | 12600411 | 5 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | U | 0 | ||||||||||
| 126004111 | 12600411 | 6 | SS | SMECTA | MONTMORILLONITE | 1 | Oral | U | 0 | ||||||||||
| 126004111 | 12600411 | 7 | SS | AMOXICILLIN. | AMOXICILLIN | 1 | Oral | U | 0 | ||||||||||
| 126004111 | 12600411 | 8 | C | SPASFON | PHLOROGLUCINOL | 1 | 0 | ||||||||||||
| 126004111 | 12600411 | 9 | C | SYNTOCINON | OXYTOCIN | 1 | 0 | ||||||||||||
| 126004111 | 12600411 | 10 | C | SERESTA | OXAZEPAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126004111 | 12600411 | 1 | HIV infection |
| 126004111 | 12600411 | 3 | HIV infection |
| 126004111 | 12600411 | 5 | Product used for unknown indication |
| 126004111 | 12600411 | 6 | Product used for unknown indication |
| 126004111 | 12600411 | 7 | Product used for unknown indication |
| 126004111 | 12600411 | 8 | Product used for unknown indication |
| 126004111 | 12600411 | 9 | Product used for unknown indication |
| 126004111 | 12600411 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126004111 | 12600411 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126004111 | 12600411 | Exposure during pregnancy | |
| 126004111 | 12600411 | Live birth | |
| 126004111 | 12600411 | Polyhydramnios | |
| 126004111 | 12600411 | Viral load increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126004111 | 12600411 | 2 | 20160405 | 0 | ||
| 126004111 | 12600411 | 4 | 20160405 | 0 | ||
| 126004111 | 12600411 | 5 | 20160204 | 0 | ||
| 126004111 | 12600411 | 6 | 20160204 | 0 | ||
| 126004111 | 12600411 | 7 | 20160204 | 0 | ||
| 126004111 | 12600411 | 8 | 201605 | 0 | ||
| 126004111 | 12600411 | 9 | 20160526 | 0 |